ArriVent BioPharma, Inc. Common Stock
(AVBP - NASDAQ)
30,33 USD
📋 Profilo Aziendale

ArriVent BioPharma, Inc. operates as a clinical-stage biopharmaceutical company that engages in the identification, development, and commercialization of medicines for the unmet medical needs of patients with cancers.

|